Compare ARMP & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | KELYA |
|---|---|---|
| Founded | N/A | 1946 |
| Country | United States | United States |
| Employees | N/A | 4900 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.5M | 340.1M |
| IPO Year | 1996 | N/A |
| Metric | ARMP | KELYA |
|---|---|---|
| Price | $7.58 | $12.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.00 | $15.00 |
| AVG Volume (30 Days) | 60.6K | ★ 475.6K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.74 | $7.98 |
| 52 Week High | $14.98 | $14.94 |
| Indicator | ARMP | KELYA |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 68.86 |
| Support Level | $7.22 | $8.30 |
| Resistance Level | $7.70 | $12.01 |
| Average True Range (ATR) | 0.68 | 0.44 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 43.10 | 84.21 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Kelly Services Inc is a specialty talent solutions company. The company operates through three reportable segments: i) Enterprise Talent Management, which provides temporary staffing, outsourcing, and permanent placement services across industrial, contact center, and clerical roles, ii) Science, Engineering & Technology, which supplies specialized talent across multiple industries, and iii) Education, which delivers staffing, placement, and executive search services to Pre-K-12 school districts and education organizations in the United States. The majority of the company's revenue is derived from the Enterprise Talent Management segment. Geographically, it generates the maximum revenue from the United States, followed by Europe and the Asia-Pacific Region.